Soufflé Therapeutics News and Activities

Acquisition, funding and merger involving Soufflé Therapeutics.

• Soufflé Therapeutics has just announced a $200 Million fundraising (posted on October 9 2025).

View the org chart displaying its 27 main executives

Most searched biographies at Soufflé Therapeutics

• Amir Nashat, Chief Executive Officer
• Victor Kotelianski, Director
• Sujal Shah, Director

Create your alert
to follow the executive moves at Soufflé Therapeutics.

Soufflé Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Soufflé Therapeutics

• Bayer and Soufflé Therapeutics announce strategic collaboration to advance cell-specific heart-targeted siRNA therapy
• Soufflé Therapeutics | Redefining how medicines are made.

Social media about Soufflé Therapeutics

• Soufflé Therapeutics on Wikipedia, Google News & Yahoo Finance
• Soufflé Therapeutics on LinkedIn, X (Twitter) & YouTube